Acquired
Miroculus Stock
Miroculus is a hands off sample-to-answer solution for molecular testing.
Sign up today and learn more about Miroculus Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Miroculus Stock
Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.
Funding History
| January 2014 | $0 |
|---|---|
| September 2014 | $500K |
| April 2015 | $2.3M |
| May 2016 | $50K |
| October 2016 | $0 |
| August 2018 | $17.2M |
Management
CTO
Jorge Soto
Chief Scientific Officer
Foteini Christodoulou
CEO
Alejandro Tocigl
EquityZen Recognized As:
